References
- Pavletic SZ, Fowler DH. Are we making progress in GVHD prophylaxis and treatment?Hematology Am Soc Hematol Education Program 2012:251–264.
- Ho VT, Cutler C. Current and novel therapies in acute GVHD. Clin Haematol 2008;21:223–237.
- Taylor JL, Palmer SM. Critical care perspective on immunotherapy in lung transplantation. J Intensive Care Med 2006;21:327–344.
- Wolff D, Ayuk F, Elmaagacli A, et al. Current practice in diagnosis and treatment of acute graft-versus-host disease: results from a survey among German-Austrian-Swiss hematopoietic stem cell transplant centers. Biol Blood Marrow Transplant 2013;19:767–776.
- Greinix HT, Knobler R. Extracorporeal photopheresis: cellular photoimmunotherapy. Berlin: de Gruyter; 2012.
- Greinix HT, Worel N, Knobler R. Role of extracorporeal photopheresis (ECP) in treatment of steroid-refractory acute graft-versus-host disease. Biol Blood Marrow Transplant 2010;16:1747–1748;author reply 1749.
- Deeg HJ. How I treat refractory acute GVHD. Blood 2007;109: 4119–4126.
- Marshall SR. Technology insight: ECP for the treatment of GvHD—can we offer selective immune control without generalized immunosuppression?Nat Clin Pract Oncol 2006;3:302–314.
- Maeda A. Extracorporeal photochemotherapy. J Dermatol Sci 2009;54:150–156.
- Morrell MR, Despotis GJ, Lublin DM, et al. The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant 2010;29:424–431.
- Reddy P, Ferrara JL. Immunobiology of acute graft-versus-host disease. Blood Rev 2003;17:187–194.
- Jaramillo A, Fernandez FG, Kuo EY, et al. Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation. Ped Transplant 2005;9:84–93.
- Heeger PS. T-cell allorecognition and transplant rejection: a summary and update. Am J Transplant 2003;3:525–533.
- D’Asaro M, Dieli F, Caccamo N, et al. Increase of CCR7- CD45RA+ CD8 T cells (TEMRA) in chronic graft-versus-host disease. Leukemia 2006;20:545–547.
- Lamioni A, Parisi F, Isacchi G, et al. The immunological effects of extracorporeal photopheresis unraveled:induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo. Transplantation 2005;79:846–850.
- Gerner M, Hölig K, Wehner R, et al. Extracorporeal photopheresis efficiently impairs the proinflammatory capacity of human 6-sulfo LacNAc dendritic cells. Transplantation 2009;87:1134–1139.
- Bastien JP, Krosl G, Therien C, et al. Photodepletion differentially affects CD4 + Tregs versus CD4 + effector T cells from patients with chronic graft-versus-host disease. Blood 2010;116:4859–4869.
- Lamioni A, Carsetti R, Legato A, et al. Induction of regulatory T cells after prophylactic treatment with photophesis in renal transplant recipients. Transfusion 2007;83:1393–1396.
- Voss C, Fry T, Coppes M, et al. Extending the horizon for cell-based immunotherapy by understanding the mechanisms of action of photopheresis. Transfusion Med Rev 2010;24:22–32.
- Maeda A, Schwarz A, Bullinger A, et al. Experimental extracorporeal photopheresis inhibits the sensitization and effector phases of contact hypersensitivity via two Mechanisms:Generation of IL-10 and induction of regulatory T cells. J Immunol 2008;181: 5956–5962.
- Hill GR, Ferrara JL. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood 2000;95:2754–2759.
- Farag SS, Fehniger TA, Ruggeri L, et al. Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect. Blood 2002;100:1935–1947.
- Boehler A, Estenne M. Post-transplant bronchiolitis obliterans. Eur Respir J 2003;22:1007–1018.
- Hodge G, Hodge S, Li-Liew C, et al. Increased natural killer T-like cells are a major source of pro-inflammatory cytokines and granzymes in lung transplant recipients. Respirology 2012;17:155–163.
- Alcindor T, Gorgun G, Miller KB, et al. Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease. Blood 2001;98: 1622–1625.
- Biagi E, Di Biaso J, Leoni V, et al. Extracorporeal photo- chemotherapy is accompanied by increasing levels of circulating CD4 + CD25+ GITR+ Foxp3 + CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. Transplantation 2007;84: 31–39.
- Di Biaso J, Di Maio L, Bugarin C, et al. Regulatory T cells and extracorporeal photochemotherapy: correlation with clinical response and decreased frequency of proinflammatory T cells. Transplantation 2009;87:1422–1425.
- Bladon J, Taylor P. Extracorporeal photopheresis normalizes some lymphocyte subsets (including T regulatory cells) in chronic graft-versus-host-disease. Ther Apher Dial 2008;12:311–318.
- Meloni F, Cascina A, Miserere S, et al. Peripheral CD4(+)CD25(+) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients. Transplant Proc 2007;39:213–217.
- Yamashita K, Horwitz ME, Kwatemaa A, et al. Unique abnormalities of CD4(+) and CD8(+) central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis. Biol Blood Marrow Transplant 2006;12:22–30.
- Tsirigotis P, Kapsimalli V, Baltadakis I, et al. Extracorporeal photopheresis in refractory chronic graft-versus-host disease: the influence on peripheral blood T cell subpopulations. A study by the Hellenic Association of Hematology. Transfus Apher Sci 2012;46: 181–188.